Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Gabriel N. Hortobágyi
Based on 305 articles published since 2007
||||
Expertise Level
The expertise of Gabriel N. Hortobágyi ranks in the
  • Top 0.00079%
  • ... of 253,558 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 305 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Hortobagyi, Gabriel N   ·   Hortobagyi, G N   ·   Hortobágyi, Gabriel N
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2017
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Medical Oncology, The National Cancer Institute, Cairo University, Cairo, Egypt. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 28368261
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA. · Department of Pathology, Amgen, Inc., Seattle, WA, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Hematology and Oncology Research, Amgen, Inc., Seattle, WA, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 28417335
  • Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA. · Pubmed 28376179
  • Executive Vice Chair, Surgery; Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA. · Professor of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA. · Vice President, Healthcare Outcomes and Policy, Roswell Park Cancer Institute, Buffalo, NY. · Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, San Francisco, CA. · Chairman, Department of Radiation Oncology, Albert Einstein Healthcare Network, Philadelphia, PA. · Professor of Pathology, University of Vermont, Burlington, VT. · Associate Director, Kellogg Cancer Surgical Services, NorthShore University HealthSystem, Evanston, IL. · Professor; Co-Director, Breast Cancer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28294295
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA. · Global Medical Affairs, Novartis Pharma AG, Basel CH-4002, Switzerland. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 28183140
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical Univesity, Taichung, Taiwan. · Department of Biotechnology, Asia University, Taichung, Taiwan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28167507
  • Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston. · Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor. · Utah Cancer Specialists, Salt Lake City, Utah. · Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Department of Internal Medicine-Hematology/Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California. · Department of Hematology/Oncology, Cancer Center of Kansas, Wichita. · Department of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey. · Consultant, AstraZeneca, London, England10Consultant, BeyondSpring Pharmaceuticals, New York, New York. · Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. · Pubmed 28125763
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology Administration, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. · Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA. · School of Medicine, University of Nottingham, Nottingham, UK. · Quintiles Transnational Corp, Denver, Colorado, USA. · Pubmed 27881578
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Currently at Department of Medical Oncology, Comenius University, School of Medicine, National Cancer Institute, Bratislava, Slovakia. · Currently at Department of Medicine at Medical University of South Carolina, Charleston, SC, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Currently at Department of Medical Oncology, The National Cancer Institute, Cairo University, Cairo, Egypt. · Currently at Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola (FC), Italy. · Currently at Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of MD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Currently at Division of Hematology-Oncology at Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 27374101
  • University of Texas M.D. Anderson Cancer Center, Houston, TX · Pubmed 28099830
2016
  • Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Pubmed 27933405
  • Centro de Oncologia do Paraná, Curitiba SP, Brazil. · Roche Pharmaceuticals, São Paulo SP, Brazil. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26824988
  • University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Heartland Cancer Research NCORP, Crossroads Cancer Center, Effingham, IL, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27475087
  • Division of Hematology-Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, Ann Arbor, MI, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI, USA. · Genentech, Inc., San Francisco, CA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Hematology Oncology Consultants, Inc., Westerville, OH, USA. · Columbus NCI Community Oncology Research Program, Columbus, OH, USA. · Loma Linda University Cancer Center, Loma Linda, CA, USA. · Gibbs Cancer Center and Research Institute/Southeast Clinical Oncology Research (SCOR) Consortium NCORP/Upstate Carolina CCOP (previous), Spartanburg, SC, USA. · Yale University, New Haven, CT, USA. · Arizona Cancer Center, Tucson, AZ, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27393622
  • Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA. · Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27287781
  • The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Chicago, Chicago, Illinois. · Duke Cancer Institute, Durham, North Carolina. · Pfizer, Groton, Connecticut. · University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Baylor University College of Medicine, Houston, Texas. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27166393
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Cancer Prevention, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, FCT9.5024, 1515 Holcombe Blvd. Unit Number: 1444, Houston, TX, 77030, USA. · , Texas, USA. · Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Cancer Prevention, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, FCT9.5024, 1515 Holcombe Blvd. Unit Number: 1444, Houston, TX, 77030, USA. · Pubmed 27522517
  • The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA. · The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA. · Pubmed 27146586
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston4Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26986538
  • College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, School of Public Health, Ann Arbor, MI, USA. · Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. · London Health Sciences Center/National Cancer Institute of Canada Clinical, Trials Group, London, ON, Canada. · Wichita NCORP, Wichita, KS, USA. · Kaiser Permanente NCORP, Portland, OR, USA. · Arizona Cancer Center, University of Arizona, Tucson, AZ, USA. · Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. · University of California Irvine Medical Center, Chao Family Comprehensive, Cancer Center, Orange, CA, USA. · Pubmed 26859101
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Genomics Research Center, Academia Sinica, Taipei, Taiwan. · Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan. · Department of Biochemistry, McGill University, Montreal, Quebec, Canada. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biotechnology, Asia University, Taichung, Taiwan. · Pubmed 26779812
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. · Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington. · Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical, University, Taichung, Taiwan. Genomics Research Center, Academia Sinica, Taipei, Taiwan. · Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical, University, Taichung, Taiwan. · Genomics Research Center, Academia Sinica, Taipei, Taiwan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical, University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Pubmed 26759242
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas. · Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. · Department of Biotechnology, Asia University, Taichung, Taiwan. Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas. · Pubmed 26759241
  • Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Center for Cancer and Blood Disorders, Arlington, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston. · Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26720612
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA · Pubmed 26659222
  • Department of Medical Oncology, Comenius University, Faculty of Medicine, St Elizabeth Cancer Institute, Bratislava, Slovak Republic. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Second Department of Medical Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovak Republic. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25975189
2015
  • Department of Medicine, Division of Hematology/Oncology, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. · Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA; School of Public Health, The University of Texas Health Science Center at Houston, 1200 Herman-Pressler Street, Houston, TX 77030, USA. · Department of Medicine, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. · Department of Medicine, Division of Hematology/Oncology, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. Electronic address: · Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1155 Pressler, Suite CPB5.3466, Houston, TX 77030, USA. · Pubmed 26343314
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 25810012
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Genentech, South San Francisco, CA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 25913905
  • Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26443806
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology, Eugène Marquis Cancer Center, Rennes, France. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 26233757
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25975349
  • All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25964256
  • University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA. · University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA · Pubmed 25948675
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Veterinary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Breast Cancer Translational Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25605252
  • 1] Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA [2] Department of Systems Biology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · 1] Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA [2] Department of Health Services Research at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25584488
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Medical Oncology, Comenius University, School of Medicine, Bratislava, Slovakia. · Present affiliation: Breast Center, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola, FC, Italy. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Department, Dubai Hospital, Dubai, UAE. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Present affiliation: Breast Center, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25572591
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: · Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Pubmed 25454687
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. · SWOG Statistical Center, Seattle, WA. · University of Texas MD Anderson Cancer Center, Houston, TX. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Pubmed 25870090
2014
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24461458
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · New York University Langone Medical Center, New York University, New York, New York. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Bristol-Myers Squibb Inc., New York, New York. · Pubmed 25172932
  • Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH, USA. · Columbia University Medical Center, Columbia University, New York, NY, USA. · Department of medicine, Baystate Medical Center, Springfield, MA, USA. · Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Mayo Clinic, Rochester, MN, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Seattle Cancer Care Alliance, Seattle, WA, USA. · College of Medicine, Arizona Cancer Center, Tucson, AZ, USA. · Loyola University Chicago Cardinal Bernardin Cancer Center, Maywood, IL, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Pubmed 23999597
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Division of Pharmacy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Obstetrics/Gynecology, The University of Texas Health Science Center, 6431 Fannin Street, Houston, TX, 77030, USA. · Department of Obstetrics/Gynecology, The University of Texas Health Science Center, 6431 Fannin Street, Houston, TX, 77030, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1362, Houston, TX, 77030, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1362, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Pubmed 25547133
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taipei, Taiwan. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate Institute for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taipei, Taiwan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgery, Mackay Memorial Hospital, Mackay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Graduate Institute for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Pubmed 24970481
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA · Pubmed 24951607
  • Stanford University School of Medicine, Stanford, CA · University of Florida Health Cancer Center, Orlando, FL. · MD Anderson Cancer Center, Houston, TX. · Dana-Farber Cancer Institute, Boston, MA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and. · Johns Hopkins Cancer Center, Baltimore, MD. · Pubmed 24888802
  • All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24868022
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and the Departments of Radiation Oncology, Biostatistics, and Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and the Departments of Radiation Oncology, Biostatistics, and Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA · Pubmed 24833589
  • Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; University of Arizona School of Medicine, Phoenix, Arizona. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: · Pubmed 24721590
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Pubmed 24416156
  • 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [3] Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Pubmed 23376849
2012
  • Breast Cancer Research Program, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, P.O. Box 301439, Houston, Texas 77230-1439, USA. · Pubmed 22474069
2010
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA. · Pubmed 20522797
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX 77030-4009, USA. · Pubmed 20454927
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 20225231
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 424, Houston, TX 77030-4009, USA. · Pubmed 20091835
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center Houston, Texas, USA. · Pubmed 21192567
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ. · George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ. · Pubmed 25422488
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, USA. · Pubmed 26272743
  • Dr. J. M. Reuben, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA, Tel.: +1 713 745 6837, Fax: +1 713 794 1838, E-mail: · Pubmed 25373787
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, · Pubmed 25038877
  • Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan; Department of Surgery, Division of Breast Surgical Oncology, The Showa University School of Medicine, Tokyo, Japan. · Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan; Department of Surgery, Division of Breast Surgical Oncology, The Showa University School of Medicine, Tokyo, Japan · Pubmed 25117064
  • Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Pubmed 24916181
  • Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Pubmed 24888818
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24796968
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24677057
  • Department of Pharmacy, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA; Division of Pharmacy and Departments of Biostatistics and NYU Cancer Institute, New York University Langone Medical Center, New York, New York, USA; Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24536030
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24510381
  • All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24470007
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
  • Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23676510
2013
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1155 Herman P Pressler CPB5.3450, Houston, TX 77030, USA. · Pubmed 23377763
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23053261
  • From The University of Texas MD Anderson Cancer Center. · Pubmed 24127446
  • Authors' Affiliations: Department of Breast Medical Oncology, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of Molecular and Cellular Oncology, Pathology, Radiation Oncology, and Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. · Pubmed 24014597
  • Authors' Affiliations: Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 23948975
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23820253
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 23798614
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Pubmed 23576478
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23562929
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23370825
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23341341
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23340302
  • Departmentsof Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23337751
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 23306905
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23299541
  • Department of Surgical Oncology,Unit 1484, The University of TexasMDAnderson Cancer Center, 1400 Pressler St, Houston, TX 77030, USA. · Pubmed 23291658
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 23242617
  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23231005
  • Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. · Pubmed 23208590
  • Departments of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030-4009, · Pubmed 23139263
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23098575
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 22736407
2012
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23073759
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22584436
  • The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology , 1515 Holcombe Boulevard, Unit 1354, Houston, TX 77030 , USA. · Pubmed 22242911
  • Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22085764
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22331946
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22281842
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22006179
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 22890751
  • Department of Molecular and Cellular Oncology, Unit 0079, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 22826466
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 22776706
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 22773664
  • The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, 1155 Herman P. Pressler, CPB5.3458, Houston, TX 77030-3721, USA. · Pubmed 22734030
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA. · Pubmed 22614988
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22591634
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 22584435
  • Department of Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22374333
  • Department of Hematology and Oncology, TheUniversity of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22371383
  • Department of Systems Biology - Unit 950, The University of Texas MD Anderson Cancer Center, 7435 Fannin Street, Houston, TX 77054, USA. · Pubmed 22343619
  • The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 22291085
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22253230
  • Departments of Breast Medical Oncology, Systems Biology, Biostatistics, Surgical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22235097
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22139648
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA. · Pubmed 22124109
  • Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22112968
  • Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22102688
  • Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22009639
  • Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21965473
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21953213
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21913181
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21837669
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21800293
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 21765048
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21761402
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21671160
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21607830
  • Divison of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21590688
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 21387303
2011
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22042786
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA. · Pubmed 21976315
  • Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center Houston, USA. · Pubmed 21585248
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22042783
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77005, USA. · Pubmed 21730275
  • The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. · Pubmed 22084362
  • Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, USA. · Pubmed 21907925
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030-4009, USA. · Pubmed 21900106
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77230-1439, USA. · Pubmed 21833625
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 21830012
  • Division of Quantitative Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA. · Pubmed 21768471
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21765193
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 21764391
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21726347
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21712485
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., 77030, Houston, TX, USA. · Pubmed 21710134
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. · Pubmed 21699723
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21656514
  • The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 21632501
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21632453
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA · Pubmed 21606433
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21509759
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 21490305
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21482989
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21399647
  • Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA · Pubmed 21393379
  • Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21365619
  • Department of Hematopathology, Unit 54, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21334874
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1354, Houston, Texas 77030, USA. · Pubmed 21266401
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 21248301
  • Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21233401
  • Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21215703
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21210173
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 21191116
  • Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21153052
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 21061075
2010
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1155 Herman P Pressler, Houston, TX 77030-1439, USA. · Pubmed 20620933
  • The University of Texas M D Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX 77030-3721, USA. · Pubmed 20530283
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20027191
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe, Box 1354, Houston, TX 77030, USA. · Pubmed 20697802
  • Department of Breast Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas; Deparment of Medical Oncology, Dubai Hospital, Dubai, UAE. · Pubmed 20626396
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20082452
  • Department of Breast Medical Oncology, The University of Texas M, D, Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21080941
  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA · Pubmed 21075308
  • Breast Cancer Translational Research Laboratory, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21045138
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20953832
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 20829329
  • Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20813970
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA. · Pubmed 20805453
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 20697068
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20665886
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20665494
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20660382
  • Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20564153
  • Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20484037
  • Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20472353
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA. · Pubmed 20439340
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20427349
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20423993
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20423989
  • Department of Breast Medical Oncology, The University of Texas,M.D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20421265
  • Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20373433
  • FACP, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 1354, Houston, TX 77030, USA. · Pubmed 20308667
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20231683
  • Breast Cancer Translational Research Laboratory, Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20215547
  • Departments of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA. <> · Pubmed 20210524
  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. · Pubmed 20104228
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301438, Houston, TX 77030, USA. · Pubmed 20052721
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 20024612
  • The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 19933921
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19875760
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, BO Box 301439, Houston, TX 77030-1439, USA. · Pubmed 19603265
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19602564
  • University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19241157
2009
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19630569
  • Breast Cancer Bone Working Group and Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19482249
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19920100
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 19884543
  • Breast Cancer Translational Research Laboratory, Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19825949
  • Department of Radiation Oncology, the Section of Health Services Research, the University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 19801315
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 19667268
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19661041
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77039, USA. · Pubmed 19596702
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030-4009, USA. · Pubmed 19487376
  • Department of Molecular and Cellular Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19470768
  • The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. · Pubmed 19451443
  • Department of Gynecologic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19435916
  • Department of Imaging Physics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19388121
  • DPhil, Departments of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 19364972
  • Division of Cancer Medicine, and Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston,TX 77030-4009, USA. · Pubmed 19307509
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 19280625
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19276248
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 19237480
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19174581
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 19150943
  • University of Texas M. D. Anderson Cancer Center, Department of Breast Medical Oncology, Unit 1354, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 19127556
Probable:    Baylor Health System   Contact    
2015
  • University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA. · University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA · Pubmed 25948675
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
Probable:    Yale University   Contact    
2014
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
2014
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
2010
  • Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA. · Pubmed 20150438
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 305 total) written by Gabriel N. Hortobágyi about Breast Neoplasms:

  • Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. 2017
  • Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression. 2017
  • Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data. 2017
  • Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. 2017
  • Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR 2017
  • PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. 2017
  • Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. 2017
  • Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial. 2017
  • Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer. 2017
  • Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Gabriel N. Hortobágyi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Baylor Health System
Yale University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2017
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Medical Oncology, The National Cancer Institute, Cairo University, Cairo, Egypt. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 28368261
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA. · Department of Pathology, Amgen, Inc., Seattle, WA, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Hematology and Oncology Research, Amgen, Inc., Seattle, WA, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 28417335
  • Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA. · Pubmed 28376179
  • Executive Vice Chair, Surgery; Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA. · Professor of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA. · Vice President, Healthcare Outcomes and Policy, Roswell Park Cancer Institute, Buffalo, NY. · Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, San Francisco, CA. · Chairman, Department of Radiation Oncology, Albert Einstein Healthcare Network, Philadelphia, PA. · Professor of Pathology, University of Vermont, Burlington, VT. · Associate Director, Kellogg Cancer Surgical Services, NorthShore University HealthSystem, Evanston, IL. · Professor; Co-Director, Breast Cancer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28294295
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA. · Global Medical Affairs, Novartis Pharma AG, Basel CH-4002, Switzerland. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 28183140
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical Univesity, Taichung, Taiwan. · Department of Biotechnology, Asia University, Taichung, Taiwan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28167507
  • Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston. · Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor. · Utah Cancer Specialists, Salt Lake City, Utah. · Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Department of Internal Medicine-Hematology/Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California. · Department of Hematology/Oncology, Cancer Center of Kansas, Wichita. · Department of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey. · Consultant, AstraZeneca, London, England10Consultant, BeyondSpring Pharmaceuticals, New York, New York. · Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. · Pubmed 28125763
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology Administration, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. · Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA. · School of Medicine, University of Nottingham, Nottingham, UK. · Quintiles Transnational Corp, Denver, Colorado, USA. · Pubmed 27881578
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Currently at Department of Medical Oncology, Comenius University, School of Medicine, National Cancer Institute, Bratislava, Slovakia. · Currently at Department of Medicine at Medical University of South Carolina, Charleston, SC, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Currently at Department of Medical Oncology, The National Cancer Institute, Cairo University, Cairo, Egypt. · Currently at Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola (FC), Italy. · Currently at Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of MD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Currently at Division of Hematology-Oncology at Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 27374101
  • University of Texas M.D. Anderson Cancer Center, Houston, TX · Pubmed 28099830
2016
  • Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Pubmed 27933405
  • Centro de Oncologia do Paraná, Curitiba SP, Brazil. · Roche Pharmaceuticals, São Paulo SP, Brazil. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26824988
  • University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Heartland Cancer Research NCORP, Crossroads Cancer Center, Effingham, IL, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27475087
  • Division of Hematology-Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, Ann Arbor, MI, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI, USA. · Genentech, Inc., San Francisco, CA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Hematology Oncology Consultants, Inc., Westerville, OH, USA. · Columbus NCI Community Oncology Research Program, Columbus, OH, USA. · Loma Linda University Cancer Center, Loma Linda, CA, USA. · Gibbs Cancer Center and Research Institute/Southeast Clinical Oncology Research (SCOR) Consortium NCORP/Upstate Carolina CCOP (previous), Spartanburg, SC, USA. · Yale University, New Haven, CT, USA. · Arizona Cancer Center, Tucson, AZ, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27393622
  • Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA. · Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27287781
  • The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Chicago, Chicago, Illinois. · Duke Cancer Institute, Durham, North Carolina. · Pfizer, Groton, Connecticut. · University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Baylor University College of Medicine, Houston, Texas. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27166393
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Cancer Prevention, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, FCT9.5024, 1515 Holcombe Blvd. Unit Number: 1444, Houston, TX, 77030, USA. · , Texas, USA. · Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Cancer Prevention, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, FCT9.5024, 1515 Holcombe Blvd. Unit Number: 1444, Houston, TX, 77030, USA. · Pubmed 27522517
  • The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA. · The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA. · Pubmed 27146586
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston4Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26986538
  • College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, School of Public Health, Ann Arbor, MI, USA. · Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. · London Health Sciences Center/National Cancer Institute of Canada Clinical, Trials Group, London, ON, Canada. · Wichita NCORP, Wichita, KS, USA. · Kaiser Permanente NCORP, Portland, OR, USA. · Arizona Cancer Center, University of Arizona, Tucson, AZ, USA. · Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. · University of California Irvine Medical Center, Chao Family Comprehensive, Cancer Center, Orange, CA, USA. · Pubmed 26859101
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Genomics Research Center, Academia Sinica, Taipei, Taiwan. · Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan. · Department of Biochemistry, McGill University, Montreal, Quebec, Canada. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biotechnology, Asia University, Taichung, Taiwan. · Pubmed 26779812
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. · Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington. · Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical, University, Taichung, Taiwan. Genomics Research Center, Academia Sinica, Taipei, Taiwan. · Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical, University, Taichung, Taiwan. · Genomics Research Center, Academia Sinica, Taipei, Taiwan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical, University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Pubmed 26759242
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas. · Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. · Department of Biotechnology, Asia University, Taichung, Taiwan. Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas. · Pubmed 26759241
  • Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Center for Cancer and Blood Disorders, Arlington, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston. · Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26720612
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA · Pubmed 26659222
  • Department of Medical Oncology, Comenius University, Faculty of Medicine, St Elizabeth Cancer Institute, Bratislava, Slovak Republic. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Second Department of Medical Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovak Republic. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25975189
2015
  • Department of Medicine, Division of Hematology/Oncology, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. · Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA; School of Public Health, The University of Texas Health Science Center at Houston, 1200 Herman-Pressler Street, Houston, TX 77030, USA. · Department of Medicine, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. · Department of Medicine, Division of Hematology/Oncology, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. Electronic address: · Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1155 Pressler, Suite CPB5.3466, Houston, TX 77030, USA. · Pubmed 26343314
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 25810012
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Genentech, South San Francisco, CA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 25913905
  • Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26443806
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology, Eugène Marquis Cancer Center, Rennes, France. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 26233757
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25975349
  • All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25964256
  • University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA. · University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA · Pubmed 25948675
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Veterinary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Section of Breast Cancer Translational Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25605252
  • 1] Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA [2] Department of Systems Biology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · 1] Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA [2] Department of Health Services Research at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25584488
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Medical Oncology, Comenius University, School of Medicine, Bratislava, Slovakia. · Present affiliation: Breast Center, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola, FC, Italy. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Department, Dubai Hospital, Dubai, UAE. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Present affiliation: Breast Center, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25572591
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: · Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. · Pubmed 25454687
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. · SWOG Statistical Center, Seattle, WA. · University of Texas MD Anderson Cancer Center, Houston, TX. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Pubmed 25870090
2014
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24461458
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · New York University Langone Medical Center, New York University, New York, New York. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Bristol-Myers Squibb Inc., New York, New York. · Pubmed 25172932
  • Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH, USA. · Columbia University Medical Center, Columbia University, New York, NY, USA. · Department of medicine, Baystate Medical Center, Springfield, MA, USA. · Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Mayo Clinic, Rochester, MN, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Seattle Cancer Care Alliance, Seattle, WA, USA. · College of Medicine, Arizona Cancer Center, Tucson, AZ, USA. · Loyola University Chicago Cardinal Bernardin Cancer Center, Maywood, IL, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Pubmed 23999597
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Division of Pharmacy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Obstetrics/Gynecology, The University of Texas Health Science Center, 6431 Fannin Street, Houston, TX, 77030, USA. · Department of Obstetrics/Gynecology, The University of Texas Health Science Center, 6431 Fannin Street, Houston, TX, 77030, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1362, Houston, TX, 77030, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1362, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA. · Pubmed 25547133
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taipei, Taiwan. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate Institute for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taipei, Taiwan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgery, Mackay Memorial Hospital, Mackay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Graduate Institute for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan. · Pubmed 24970481
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA · Pubmed 24951607
  • Stanford University School of Medicine, Stanford, CA · University of Florida Health Cancer Center, Orlando, FL. · MD Anderson Cancer Center, Houston, TX. · Dana-Farber Cancer Institute, Boston, MA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and. · Johns Hopkins Cancer Center, Baltimore, MD. · Pubmed 24888802
  • All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24868022
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and the Departments of Radiation Oncology, Biostatistics, and Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and the Departments of Radiation Oncology, Biostatistics, and Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA · Pubmed 24833589
  • Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; University of Arizona School of Medicine, Phoenix, Arizona. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: · Pubmed 24721590
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Pubmed 24416156
  • 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [3] Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Pubmed 23376849
2012
  • Breast Cancer Research Program, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, P.O. Box 301439, Houston, Texas 77230-1439, USA. · Pubmed 22474069
2010
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA. · Pubmed 20522797
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX 77030-4009, USA. · Pubmed 20454927
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 20225231
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 424, Houston, TX 77030-4009, USA. · Pubmed 20091835
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center Houston, Texas, USA. · Pubmed 21192567
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ. · George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ. · Pubmed 25422488
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, USA. · Pubmed 26272743
  • Dr. J. M. Reuben, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA, Tel.: +1 713 745 6837, Fax: +1 713 794 1838, E-mail: · Pubmed 25373787
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, · Pubmed 25038877
  • Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan; Department of Surgery, Division of Breast Surgical Oncology, The Showa University School of Medicine, Tokyo, Japan. · Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan; Department of Surgery, Division of Breast Surgical Oncology, The Showa University School of Medicine, Tokyo, Japan · Pubmed 25117064
  • Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Pubmed 24916181
  • Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Pubmed 24888818
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24796968
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24677057
  • Department of Pharmacy, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA; Division of Pharmacy and Departments of Biostatistics and NYU Cancer Institute, New York University Langone Medical Center, New York, New York, USA; Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24536030
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24510381
  • All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24470007
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
  • Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23676510
2013
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1155 Herman P Pressler CPB5.3450, Houston, TX 77030, USA. · Pubmed 23377763
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23053261
  • From The University of Texas MD Anderson Cancer Center. · Pubmed 24127446
  • Authors' Affiliations: Department of Breast Medical Oncology, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of Molecular and Cellular Oncology, Pathology, Radiation Oncology, and Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. · Pubmed 24014597
  • Authors' Affiliations: Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 23948975
  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23820253
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 23798614
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Pubmed 23576478
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23562929
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23370825
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23341341
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23340302
  • Departmentsof Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23337751
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 23306905
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23299541
  • Department of Surgical Oncology,Unit 1484, The University of TexasMDAnderson Cancer Center, 1400 Pressler St, Houston, TX 77030, USA. · Pubmed 23291658
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 23242617
  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23231005
  • Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. · Pubmed 23208590
  • Departments of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030-4009, · Pubmed 23139263
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23098575
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 22736407
2012
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23073759
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22584436
  • The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology , 1515 Holcombe Boulevard, Unit 1354, Houston, TX 77030 , USA. · Pubmed 22242911
  • Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22085764
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22331946
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22281842
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22006179
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 22890751
  • Department of Molecular and Cellular Oncology, Unit 0079, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 22826466
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 22776706
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 22773664
  • The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, 1155 Herman P. Pressler, CPB5.3458, Houston, TX 77030-3721, USA. · Pubmed 22734030
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA. · Pubmed 22614988
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22591634
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 22584435
  • Department of Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22374333
  • Department of Hematology and Oncology, TheUniversity of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22371383
  • Department of Systems Biology - Unit 950, The University of Texas MD Anderson Cancer Center, 7435 Fannin Street, Houston, TX 77054, USA. · Pubmed 22343619
  • The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 22291085
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22253230
  • Departments of Breast Medical Oncology, Systems Biology, Biostatistics, Surgical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22235097
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22139648
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA. · Pubmed 22124109
  • Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22112968
  • Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22102688
  • Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22009639
  • Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21965473
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21953213
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21913181
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21837669
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21800293
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 21765048
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21761402
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21671160
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21607830
  • Divison of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21590688
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 21387303
2011
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22042786
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA. · Pubmed 21976315
  • Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center Houston, USA. · Pubmed 21585248
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22042783
  • The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77005, USA. · Pubmed 21730275
  • The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. · Pubmed 22084362
  • Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, USA. · Pubmed 21907925
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030-4009, USA. · Pubmed 21900106
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77230-1439, USA. · Pubmed 21833625
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 21830012
  • Division of Quantitative Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA. · Pubmed 21768471
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21765193
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 21764391
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21726347
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21712485
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., 77030, Houston, TX, USA. · Pubmed 21710134
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. · Pubmed 21699723
  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21656514
  • The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 21632501
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21632453
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA · Pubmed 21606433
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21509759
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 21490305
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21482989
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21399647
  • Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA · Pubmed 21393379
  • Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21365619
  • Department of Hematopathology, Unit 54, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21334874
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1354, Houston, Texas 77030, USA. · Pubmed 21266401
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 21248301
  • Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 21233401
  • Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21215703
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21210173
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 21191116
  • Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21153052
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 21061075
2010
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1155 Herman P Pressler, Houston, TX 77030-1439, USA. · Pubmed 20620933
  • The University of Texas M D Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX 77030-3721, USA. · Pubmed 20530283
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20027191
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe, Box 1354, Houston, TX 77030, USA. · Pubmed 20697802
  • Department of Breast Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas; Deparment of Medical Oncology, Dubai Hospital, Dubai, UAE. · Pubmed 20626396
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20082452
  • Department of Breast Medical Oncology, The University of Texas M, D, Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21080941
  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA · Pubmed 21075308
  • Breast Cancer Translational Research Laboratory, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21045138
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20953832
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 20829329
  • Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20813970
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA. · Pubmed 20805453
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 20697068
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20665886
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20665494
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20660382
  • Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20564153
  • Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20484037
  • Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20472353
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA. · Pubmed 20439340
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20427349
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20423993
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20423989
  • Department of Breast Medical Oncology, The University of Texas,M.D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20421265
  • Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20373433
  • FACP, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 1354, Houston, TX 77030, USA. · Pubmed 20308667
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20231683
  • Breast Cancer Translational Research Laboratory, Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20215547
  • Departments of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA. <> · Pubmed 20210524
  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. · Pubmed 20104228
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301438, Houston, TX 77030, USA. · Pubmed 20052721
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 20024612
  • The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 19933921
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19875760
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, BO Box 301439, Houston, TX 77030-1439, USA. · Pubmed 19603265
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19602564
  • University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19241157
2009
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19630569
  • Breast Cancer Bone Working Group and Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19482249
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19920100
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 19884543
  • Breast Cancer Translational Research Laboratory, Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19825949
  • Department of Radiation Oncology, the Section of Health Services Research, the University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 19801315
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 19667268
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19661041
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77039, USA. · Pubmed 19596702
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030-4009, USA. · Pubmed 19487376
  • Department of Molecular and Cellular Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19470768
  • The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. · Pubmed 19451443
  • Department of Gynecologic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19435916
  • Department of Imaging Physics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19388121
  • DPhil, Departments of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 19364972
  • Division of Cancer Medicine, and Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston,TX 77030-4009, USA. · Pubmed 19307509
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 19280625
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19276248
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 19237480
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19174581
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 19150943
  • University of Texas M. D. Anderson Cancer Center, Department of Breast Medical Oncology, Unit 1354, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 19127556
Baylor Health System
2015
  • University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA. · University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA · Pubmed 25948675
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
Yale University
2014
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
2014
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
2010
  • Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA. · Pubmed 20150438
Unspecified
2014
  • Department of Breast Medical Oncology Department of Systems Biology · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology. · Genenetech, San Francisco. · Departments of Biostatistics. · Clinical Cancer Prevention. · Radiology. · Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Division of Hematology-Oncology, Yale University, New Haven. · Department of Systems Biology. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 24669015
2014
2013
Texas A and M University
2014
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
107 Other Locations Show
Yearly article counts 011181736394748583100